Literature DB >> 29730775

DNA methylation-based reclassification of olfactory neuroblastoma.

David Capper1,2,3,4,5, Nils W Engel6,7, Damian Stichel1, Matt Lechner8,9,10, Stefanie Glöss3,4,5, Simone Schmid3,4,5, Christian Koelsche1,2, Daniel Schrimpf1,2, Judith Niesen11,12, Annika K Wefers1,2, David T W Jones13,14, Martin Sill13,14, Oliver Weigert15, Keith L Ligon16, Adriana Olar17, Arend Koch3, Martin Forster9,10, Sebastian Moran18, Oscar M Tirado19, Miguel Sáinz-Jaspeado19, Jaume Mora20, Manel Esteller18,21,22, Javier Alonso23, Xavier Garcia Del Muro24, Werner Paulus25, Jörg Felsberg26,27, Guido Reifenberger26,27, Markus Glatzel28, Stephan Frank29, Camelia M Monoranu30, Valerie J Lund8,10, Andreas von Deimling1,2, Stefan Pfister13,14,31, Rolf Buslei32,33, Julika Ribbat-Idel34,35,36, Sven Perner34,35,36, Volker Gudziol37, Matthias Meinhardt38, Ulrich Schüller39,40,41,42.   

Abstract

Olfactory neuroblastoma/esthesioneuroblastoma (ONB) is an uncommon neuroectodermal neoplasm thought to arise from the olfactory epithelium. Little is known about its molecular pathogenesis. For this study, a retrospective cohort of n = 66 tumor samples with the institutional diagnosis of ONB was analyzed by immunohistochemistry, genome-wide DNA methylation profiling, copy number analysis, and in a subset, next-generation panel sequencing of 560 tumor-associated genes. DNA methylation profiles were compared to those of relevant differential diagnoses of ONB. Unsupervised hierarchical clustering analysis of DNA methylation data revealed four subgroups among institutionally diagnosed ONB. The largest group (n = 42, 64%, Core ONB) presented with classical ONB histology and no overlap with other classes upon methylation profiling-based t-distributed stochastic neighbor embedding (t-SNE) analysis. A second DNA methylation group (n = 7, 11%) with CpG island methylator phenotype (CIMP) consisted of cases with strong expression of cytokeratin, no or scarce chromogranin A expression and IDH2 hotspot mutation in all cases. T-SNE analysis clustered these cases together with sinonasal carcinoma with IDH2 mutation. Four cases (6%) formed a small group characterized by an overall high level of DNA methylation, but without CIMP. The fourth group consisted of 13 cases that had heterogeneous DNA methylation profiles and strong cytokeratin expression in most cases. In t-SNE analysis, these cases mostly grouped among sinonasal adenocarcinoma, squamous cell carcinoma, and undifferentiated carcinoma. Copy number analysis indicated highly recurrent chromosomal changes among Core ONB with a high frequency of combined loss of chromosome 1-4, 8-10, and 12. NGS sequencing did not reveal highly recurrent mutations in ONB, with the only recurrently mutated genes being TP53 and DNMT3A. In conclusion, we demonstrate that institutionally diagnosed ONB are a heterogeneous group of tumors. Expression of cytokeratin, chromogranin A, the mutational status of IDH2 as well as DNA methylation patterns may greatly aid in the precise classification of ONB.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29730775     DOI: 10.1007/s00401-018-1854-7

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   15.887


  12 in total

1.  Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course.

Authors:  Annika K Wefers; Damian Stichel; Daniel Schrimpf; Roland Coras; Mélanie Pages; Arnault Tauziède-Espariat; Pascale Varlet; Daniel Schwarz; Figen Söylemezoglu; Ute Pohl; José Pimentel; Jochen Meyer; Ekkehard Hewer; Anna Japp; Abhijit Joshi; David E Reuss; Annekathrin Reinhardt; Philipp Sievers; M Belén Casalini; Azadeh Ebrahimi; Kristin Huang; Christian Koelsche; Hu Liang Low; Olinda Rebelo; Dina Marnoto; Albert J Becker; Ori Staszewski; Michel Mittelbronn; Martin Hasselblatt; Jens Schittenhelm; Edmund Cheesman; Ricardo Santos de Oliveira; Rosane Gomes P Queiroz; Elvis Terci Valera; Volkmar H Hans; Andrey Korshunov; Adriana Olar; Keith L Ligon; Stefan M Pfister; Zane Jaunmuktane; Sebastian Brandner; Ruth G Tatevossian; David W Ellison; Thomas S Jacques; Mrinalini Honavar; Eleonora Aronica; Maria Thom; Felix Sahm; Andreas von Deimling; David T W Jones; Ingmar Blumcke; David Capper
Journal:  Acta Neuropathol       Date:  2019-09-28       Impact factor: 17.088

Review 2.  Management of olfactory neuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma involving the skullbase.

Authors:  Gautam U Mehta; Shaan M Raza; Shirley Y Su; Ehab Y Hanna; Franco DeMonte
Journal:  J Neurooncol       Date:  2020-05-18       Impact factor: 4.130

3.  Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma.

Authors:  Matt Lechner; Yoko Takahashi; Mario Turri-Zanoni; Jacklyn Liu; Nicholas Counsell; Mario Hermsen; Raman Preet Kaur; Tianna Zhao; Murugappan Ramanathan; Volker H Schartinger; Oscar Emanuel; Sam Helman; Jordan Varghese; Jozsef Dudas; Herbert Riechelmann; Susanne Sprung; Johannes Haybaeck; David Howard; Nils Wolfgang Engel; Sarah Stewart; Laura Brooks; Jessica C Pickles; Thomas S Jacques; Tim R Fenton; Luke Williams; Francis M Vaz; Paul O'Flynn; Paul Stimpson; Simon Wang; S Alam Hannan; Samit Unadkat; Jonathan Hughes; Raghav Dwivedi; Cillian T Forde; Premjit Randhawa; Simon Gane; Jonathan Joseph; Peter J Andrews; Gary Royle; Alessandro Franchi; Roberta Maragliano; Simonetta Battocchio; Helen Bewicke-Copley; Christodoulos Pipinikas; Amy Webster; Chrissie Thirlwell; Debbie Ho; Andrew Teschendorff; Tianyu Zhu; Christopher D Steele; Nischalan Pillay; Bart Vanhaesebroeck; Ahmed Mohyeldin; Juan Fernandez-Miranda; Ki Wan Park; Quynh-Thu Le; Robert B West; Rami Saade; R Peter Manes; Sacit Bulent Omay; Eugenia M Vining; Benjamin L Judson; Wendell G Yarbrough; Maddalena Sansovini; Nicolini Silvia; Ilaria Grassi; Alberto Bongiovanni; David Capper; Ulrich Schüller; Selvam Thavaraj; Ann Sandison; Pavol Surda; Claire Hopkins; Marco Ferrari; Davide Mattavelli; Vittorio Rampinelli; Fabio Facchetti; Piero Nicolai; Paolo Bossi; Oswaldo A Henriquez; Kelly Magliocca; C Arturo Solares; Sarah K Wise; Jose L Llorente; Zara M Patel; Jayakar V Nayak; Peter H Hwang; Peter D Lacy; Robbie Woods; James P O'Neill; Amrita Jay; Dawn Carnell; Martin D Forster; Masaru Ishii; Nyall R London; Diana M Bell; Gary L Gallia; Paolo Castelnuovo; Stefano Severi; Valerie J Lund; Ehab Y Hanna
Journal:  Eur J Cancer       Date:  2021-12-31       Impact factor: 10.002

Review 4.  The genomics and epigenetics of olfactory neuroblastoma: A systematic review.

Authors:  Raman Preet Kaur; Evgeny Izumchenko; Dukagjin M Blakaj; Nikol Mladkova; Matt Lechner; Thomas L Beaumont; Charalampos S Floudas; Gary L Gallia; Nyall R London
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-06-07

Review 5.  Novel Biomarkers in Sinonasal Cancers: from Bench to Bedside.

Authors:  Matt Lechner; Jacklyn Liu; Valerie J Lund
Journal:  Curr Oncol Rep       Date:  2020-07-29       Impact factor: 5.075

6.  Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience.

Authors:  David Capper; Damian Stichel; Felix Sahm; David T W Jones; Daniel Schrimpf; Martin Sill; Simone Schmid; Volker Hovestadt; David E Reuss; Christian Koelsche; Annekathrin Reinhardt; Annika K Wefers; Kristin Huang; Philipp Sievers; Azadeh Ebrahimi; Anne Schöler; Daniel Teichmann; Arend Koch; Daniel Hänggi; Andreas Unterberg; Michael Platten; Wolfgang Wick; Olaf Witt; Till Milde; Andrey Korshunov; Stefan M Pfister; Andreas von Deimling
Journal:  Acta Neuropathol       Date:  2018-07-02       Impact factor: 17.088

7.  DNA methylation-based classification of malformations of cortical development in the human brain.

Authors:  Samir Jabari; Katja Kobow; Andreas von Deimling; Ingmar Blümcke; Tom Pieper; Till Hartlieb; Manfred Kudernatsch; Tilman Polster; Christian G Bien; Thilo Kalbhenn; Matthias Simon; Hajo Hamer; Karl Rössler; Martha Feucht; Angelika Mühlebner; Imad Najm; José Eduardo Peixoto-Santos; Antonio Gil-Nagel; Rafael Toledano Delgado; Angel Aledo-Serrano; Yanghao Hou; Roland Coras
Journal:  Acta Neuropathol       Date:  2021-11-19       Impact factor: 17.088

8.  IDH2 R172 Mutations Across Poorly Differentiated Sinonasal Tract Malignancies: Forty Molecularly Homogenous and Histologically Variable Cases With Favorable Outcome.

Authors:  Stefanie Glöss; Philipp Jurmeister; Anne Thieme; Simone Schmid; Wei Y Cai; Rene N Serrette; Sven Perner; Julika Ribbat-Idel; Axel Pagenstecher; Hendrik Bläker; Ursula Keber; Christine Stadelmann; Sabrina Zechel; Pascal D Johann; Martin Hasselblatt; Werner Paulus; Christian Thomas; Hildegard Dohmen; Daniel Baumhoer; Stephan Frank; Abbas Agaimy; Ulrich Schüller; Varshini Vasudevaraja; Matija Snuderl; Cheng Z Liu; David G Pfister; Achim A Jungbluth; Ronald A Ghossein; Bin Xu; David Capper; Snjezana Dogan
Journal:  Am J Surg Pathol       Date:  2021-09-01       Impact factor: 6.298

9.  Epigenome-wide association study reveals CpG sites related to COG of neuroblastoma.

Authors:  Hao Zhao; Xiaojun Zhou; Hu Sun; Dongyun Zhao; Hongfei Liu; Bin Huang; Xingang Li; Yinghao Gu
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

Review 10.  Molecular Biomarkers in Sinonasal Cancers: New Frontiers in Diagnosis and Treatment.

Authors:  Mario Turri-Zanoni; Giacomo Gravante; Paolo Castelnuovo
Journal:  Curr Oncol Rep       Date:  2022-01-20       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.